Clinical Trial Update: An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration [Phase 2]

View source ↗

Summary

An open-label Phase 2 clinical trial evaluating the clinical and economic benefits of the I-Ray radiation therapy system for choroidal neovascularization associ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Wet Age-related Macular Degeneration

Drugs mentioned

• I-Ray

Snippet

Sponsor: Oraya Therapeutics, Inc. | Conditions: Age-Related Macular Degeneration, Wet Macular Degeneration | Phase 2 | Status: UNKNOWN